Approval · Notice of Compliance 14420 · 2013
MYLAN-NITRO PATCH 0.2: Notice of Compliance 14420
Issued June 4, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14420
- Date
- June 4, 2013
- Company
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antianginal agent
- Canadian reference product
- NITRO-DUR (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYLAN-NITRO PATCH 0.2 | 02407442 | Marketed |
| MYLAN-NITRO PATCH 0.4 | 02407450 | Marketed |
| MYLAN-NITRO PATCH 0.6 | 02407469 | Marketed |
| MYLAN-NITRO PATCH 0.8 | 02407477 | Marketed |
Medicinal ingredients
- NITROGLYCERIN 20.7 MG per PATCH
- NITROGLYCERIN 41.4 MG per PATCH
- NITROGLYCERIN 62.2 MG per PATCH
- NITROGLYCERIN 82.9 MG per PATCH